-+ 0.00%
-+ 0.00%
-+ 0.00%

Truist Securities Maintains Buy on Elevance Health, Lowers Price Target to $375

Benzinga·04/13/2026 16:57:55
Listen to the news
Truist Securities analyst David Macdonald maintains Elevance Health (NYSE:ELV) with a Buy and lowers the price target from $390 to $375.